Exocytosis is the main mechanism enabling neuronal communication. This phenomenon is based on the fusion of a neurotransmitter-filled vesicle with the cell membrane, inducing the release of its content into the extracellular space.^[@ref1]^ The released neurotransmitters can then stimulate another neuron, thus enabling signal transmission.

Single cell amperometry can be used for the real-time, quantitative analysis of single exocytotic events.^[@ref2]−[@ref4]^ In this method, a 5-μm carbon fiber microelectrode is used to oxidize, in a diffusion-limited manner, the neurotransmitters released from the vesicle. This method has been extensively used to investigate the biophysical regulation of exocytosis and the dynamics of the fusion pore formed between the vesicle and the membrane.^[@ref5]−[@ref9]^ It has also been found that the vesicles might not release all their content during exocytosis, but only about 40%,^[@ref10],[@ref11]^ and that the pore does not fully dilate during the course of the event.^[@ref12]^ Partial release, or an extended version of kiss-and-run,^[@ref10]^ might then be the main mode of neuronal communication.^[@ref13]^

Even though the regulation of the fusion pore on exocytosis has been widely studied, the effects of the physical properties of the extracellular and intracellular environments have not been considered carefully. As shown in Figure [1](#fig1){ref-type="fig"}, the cell is often modeled as a lipid membrane separating two aqueous solutions. However, a cell is actually coated with a glycoprotein matrix and filled with organelles, vesicles, and an actin cytoskeleton. These structures are expected to hinder the dynamics of exocytosis by adding new constraints on the system. For instance, the glycocalyx, a biopolymer coating the cell outer membrane, has recently been found to significantly slow down the exocytotic bolus.^[@ref14],[@ref15]^ Inside the cell, the cytoskeleton, especially actin, has been found to be involved in exocytosis.^[@ref16]^ It has been suggested, based on near field microscopic imaging, that the actin cytoskeleton might constrain the fusion pore,^[@ref17]^ through depolymerization and rearrangement of actin filaments during exocytosis.^[@ref18]^ Thus, we put forward the hypothesis that, for the case of partial release of the vesicular content,^[@ref10],[@ref11]^ actin filaments might also be involved in regulating the vesicular fraction released.

![Model *versus* real system. Contrary to the theoretical model where exocytosis occurs in a free aqueous buffer, the intracellular and extracellular spaces are in reality filled with polymers, scaffolds, vesicles, and organelles.](cb-2013-00665f_0002){#fig1}

In this report, single cell amperometry has been used to investigate the effect of a 30-min incubation with 1 μM latrunculin A (latA), an inhibitor of actin polymerization,^[@ref18],[@ref19]^ in HEPES buffer with 0.1% DMSO, on the dynamics and amount of dopamine released during exocytosis in PC12 cells. These experimental results suggest that the actin cytoskeletal scaffold contributes to the closing dynamics of the pore. Release data were also compared to the effect of the dopamine precursor [l]{.smallcaps}-DOPA ([l]{.smallcaps}-3,4-dihydroxyphenylalanine) to investigate and contrast the role of vesicular packing.^[@ref11]^

Results and Discussion {#sec2}
======================

Experimental Design {#sec2.1}
-------------------

Several roles have been described for actin in exocytosis.^[@ref20],[@ref21]^ It is involved in the transport of the vesicles to the periphery of the cell.^[@ref22]^ Then, the vesicles interact with the dense mesh of actin localized in this region. The actin filaments are here expected to contribute to the priming, docking, and coating of the vesicle during the final prefusion steps.^[@ref20],[@ref23],[@ref24]^

In this study we mostly aim at hindering the final actin-vesicle interactions, so that the impact of actin filaments on the characteristics of exocytosis can be elucidated. A decrease in the vesicular trafficking or docking induced by the latA treatment would mostly result in a decrease of the cell exocytotic capability.^[@ref25],[@ref26]^ To avoid this, we have used, for the latA exposure, parameters suggested by others (ref ([@ref18]), 30-min incubation in 1 μM latA). In their report, the authors have observed an increase in the number of exocytotic events recorded per cell after this treatment. A similar effect has been observed in our results, as detailed below. The relatively short (30-min) incubation time guarantees that the impaired vesicle transport and recycling do not have an impact on the experiment. Most of the events recorded in our case then probably arise from vesicles primed and docked to the membrane region before the trafficking properties of the cytoskeleton are abolished by latA. To further ensure the impairments of the vesicular trafficking, recycling, and docking do not hinder our results by depleting the pool of readily available vesicles, each cell was stimulated only once.

Additionally, it has been reported that the effect of latA can be reversed after a few minutes in the absence of the drug.^[@ref27]^ For this reason, the supernatant containing the drug was left over the cells during the measurements. This also minimizes the manipulations of the cells.

Inhibition of Actin Cross-Linking Alters the Exocytotic Response {#sec2.2}
----------------------------------------------------------------

As shown in Figure [2](#fig2){ref-type="fig"}A, a carbon fiber microelectrode, held at 700 mV, is manipulated to a PC12 cell and positioned against its surface. Exocytosis is triggered by stimulating the cell with a 100 mM K^+^ solution, eventually leading to the recording of a train of peaks (Figure [3](#fig3){ref-type="fig"}). Several parameters can be obtained from each individual exocytotic event: the 25--75% rise time, *t*~rise~; the half peak width, *t*~1*/*2~; the 75--25% fall time, *t*~fall~; and the number of molecules released, *N*, obtained by integrating the area under the peak, as shown in Figure [2](#fig2){ref-type="fig"}B.^[@ref28]^ Typical traces obtained from the control (30-min incubation in HEPES buffer with 0.1% DMSO) and latA treatments are shown in Figure [3](#fig3){ref-type="fig"}A. In both cases, the 5-s stimulation is followed by a train of spikes. By looking at the average events obtained from these traces, it is observed that the latA treatment induces the release of slightly higher and broader events. Additionally, the latA-treated cells display a higher number of events per cell (Figure [3](#fig3){ref-type="fig"}B). This is, in part, due to the larger events obtained after latA incubation, thus facilitating the detection of the peaks. More importantly, exposure to latA almost doubles the amount of neurotransmitters released during the first 30 s of the experiments, as shown in Figure [3](#fig3){ref-type="fig"}C. Altogether, these data suggest that latA might be involved in inducing a larger fusion pore connecting the vesicle to the membrane, already suggesting that actin is involved in the dynamic regulation of exocytosis (Figure [3](#fig3){ref-type="fig"}A).

![Setup and data processing. (A) Optical micrograph of the setup, showing the stimulation pipet, the PC12 cell, and the microelectrode before it is positioned over the cell (the black bar indicates 50 μm). (B) Scheme showing the different parameters used for the peak analysis. The number of molecules released is evaluated with Faraday's law (*N* = *Q*/*nF*), where *N* is in moles; *Q* is the area under the peak, shown in gray; *n* is the number of electrons in the oxidation reaction; and *F* is Faraday's constant.](cb-2013-00665f_0003){#fig2}

![(A) Typical traces obtained from control (top), 1 μM latA-treated (center), and 100 μM [l]{.smallcaps}-DOPA-treated (bottom) cells. The black bar indicates the 5-s K^+^ stimulation. On the right side of each trace, the corresponding average peak and a representation of the suggested exocytotic system corresponding to each treatment, with latA widening the fusion pore and [l]{.smallcaps}-DOPA generating larger vesicles,^[@ref11],[@ref29],[@ref30]^ are shown. (B) Average cumulative number of events recorded and C) average cumulative number of molecules released per cell for the first 30 s of the experiment for the control (10 cells, 216 peaks), 1 μM latA (10 cells, 291 peaks), and 100 μM [l]{.smallcaps}-DOPA (5 cells, 122 peaks) treatments.](cb-2013-00665f_0004){#fig3}

The peak parameters obtained from these treatments are summarized in Table [1](#tbl1){ref-type="other"}. From these data, it appears that the disruption of the actin scaffold leads to a substantial increase in *t*~fall~ and in *i*~p~, thus lengthening the time the event takes place. This increase results in a higher amount, *N*, of molecules released. Assuming an extended kiss-and-run or partial release mechanism, these variations indicate that the cells release a higher fraction of their content after exposure to latA. Additionally, the higher *i*~p~ is evidence of a wider pore when the actin matrix is disrupted. This suggests that the actin cytoskeleton is responsible, in part, for constraining the pore dilation, perhaps by increasing the rigidity of the intracellular environment.

###### Experimental Results for *t*~rise~, *t*~1/2~, *t*~fall~, *i*~p~, and *N* Obtained from K^+^-Stimulated PC12 Cells[a](#t1fn1){ref-type="table-fn"}

  treatment                     *t*~rise~ (ms)   *t*~1/2~ (ms)    *t*~fall~ (ms)   *i*~p~ (pA)       *N*/10^3^ molecules
  ----------------------------- ---------------- ---------------- ---------------- ----------------- ---------------------
  control                       0.7 (0.4--1.2)   3.0 (1.9--4.1)   2.4 (1.5--3.7)   6.5 (4.2--11.7)   91 (63--118)
  1 μM latA                     0.7 (0.4--1.2)   3.3 (2.3--4.3)   2.8 (1.8--4.0)   8.3 (4.8--13.8)   127 (91--193)
  variation                     +1% (0.07804)    +12% (0.0299)    +16% (0.0079)    +27% (0.0077)     +40% (0.0000)
  100 μM [l]{.smallcaps}-DOPA   0.6 (0.4--0.9)   4.3 (3.1--5.3)   4.8 (3.3--6.3)   8.5 (6.7--12.9)   160 (124--237)
  variation                     --14% (0.2622)   +44% (0.0000)    +98% (0.0000)    +32% (0.0000)     +77% (0.0000)

Comparing control (10 cells, 216 peaks) to exposure to 1 μM latA (10 cells, 291 peaks) and to 100 μM [l]{.smallcaps}-DOPA treatments (5 cells, 122 peaks). The data are presented as median (1st quartile--3rd quartile). The variation of the median in comparison to the control is also reported. The pairs of data sets were compared using a two-tailed Wilcoxon--Mann--Whitney rank-sum test, and the result is indicated, between brackets, next to the variation of the median. Means are reported in the [Supporting Information](#notes-1){ref-type="notes"}.

Effect of Increased Vesicular Packing {#sec2.3}
-------------------------------------

To ensure the results observed after the latA treatment are not due to an increase in vesicular content, the effect of latA has been compared to the results obtained from the 30-min incubation of cells in 100 μM [l]{.smallcaps}-DOPA (in HEPES buffer, with 0.1% DMSO). [l]{.smallcaps}-DOPA is a synthetic precursor to dopamine, known to increase the vesicular content.^[@ref11]^ Clear exocytotic peaks were again observed upon K^+^ stimulation (Figure [3](#fig3){ref-type="fig"}A), and the [l]{.smallcaps}-DOPA increased the number of events recorded per cell in a magnitude similar to the latA. However, the increase in the total amount of neurotransmitter released was higher than for latA (about 3 times the amount released for the control; see Figure [3](#fig3){ref-type="fig"}C). This fact is in good agreement with the increased vesicular packing induced by the [l]{.smallcaps}-DOPA, and thus the effects of the latA and [l]{.smallcaps}-DOPA treatments are quantitatively different.

The results obtained comparing the exocytotic peak parameters are presented in Table [1](#tbl1){ref-type="other"}. From these values, it appears that [l]{.smallcaps}-DOPA induces a higher increase in *N* than latA, even for a short 30-min incubation. Additionally, it also increases the characteristic peak times, *t*~1*/*2~ and *t*~fall~, and *i*~p~. Again, these effects are much more potent than after latA incubation.

However, as shown in Figure [4](#fig4){ref-type="fig"}, the [l]{.smallcaps}-DOPA treatment shifts the distribution of *N* to the right, in a much more dramatic manner than after latA exposure, and small events are not observed anymore. On the contrary, events below 50,000 molecules could still be recorded following latA treatment. This fact suggests that [l]{.smallcaps}-DOPA and latA alter the exocytotic peaks *via* different pathways (**i.e.**, vesicular content *vs* pore dynamics, respectively). The same phenomenon is observed with *t*~1/2~, where [l]{.smallcaps}-DOPA treatment completely abolishes the observation of short half-times. Finally, the general distribution of *i*~p~ is largely unmodified for the latA treatment and is strongly shifted toward higher values after [l]{.smallcaps}-DOPA incubation.

![Histograms for the number of molecules released, *N*, the half-time, *t*~1/2~, and the peak current, *i*~p~, for the control, 1 μM latA, and 100 μM [l]{.smallcaps}-DOPA treatments; the blue dotted bars indicate the position of the maximum of the distribution for control. From the data shown on the histograms, 1 μM latA is interpreted to induce a wider pore opening, and the 100 μM [l]{.smallcaps}-DOPA treatment is known to increase the vesicular size and content.^[@ref11],[@ref29],[@ref30]^ The right side of the figure shows a model of the exocytotic vesicle, corresponding to each treatment, with latA widening the fusion pore and [l]{.smallcaps}-DOPA generating larger vesicles.](cb-2013-00665f_0005){#fig4}

From this analysis, the variations in the peak shape after incubation with [l]{.smallcaps}-DOPA are different from what was observed after exposure to latA, indicating that the higher release amount is not due to an increased vesicular content. The effects of latA and [l]{.smallcaps}-DOPA appear to be quantitatively different. The effect of [l]{.smallcaps}-DOPA, in good agreement with its reported effect on vesicular content, leads to higher currents, a larger amount released, and a general broadening of the spike. On the other hand, latA does not dramatically change the shape of the peak, apart from a noticeable increase in fall time. From this analysis, it can be reasonably assumed that these two drugs modify different characteristics of the system: [l]{.smallcaps}-DOPA increases the size and transmitter load of the vesicle,^[@ref11]^ and latA induces a wider fusion pore (Figures [3](#fig3){ref-type="fig"}A and [4](#fig4){ref-type="fig"}).

Actin Contributes to the Late Kinetic Characteristics of the Pore {#sec2.4}
-----------------------------------------------------------------

To clearly establish the role of actin and to show unambiguously that latA and [l]{.smallcaps}-DOPA have different effects on the vesicle, the decaying part of the peak was investigated. Indeed, if the latA treatment induces a wider pore, and somehow impedes the closing of the pore, the shape of this section of the peak will be altered, in comparison to control and to [l]{.smallcaps}-DOPA-treated cells. Assuming a partial release mechanism, the peaks obtained from latA-treated cells should be altered to a greater extent by the depletion of the neurotransmitter during partial release as the open pore should allow a higher fraction of release. The pore dynamics should be the same for [l]{.smallcaps}-DOPA *versus* control cells, so this should not happen. Indeed, even though [l]{.smallcaps}-DOPA is known to alter the fusion pore,^[@ref29],[@ref30]^ the vesicular fraction released in [l]{.smallcaps}-DOPA-treated cells has been found to be similar to the one observed in control cells.^[@ref11]^ This would therefore indicate that the respective contributions of the pore dynamics and the vesicular depletion are largely comparable in these two cases. In good agreement with this idea, latA and [l]{.smallcaps}-DOPA have been found to induce an increase of *t*~fall~, but these two treatments have different effects on the distributions of this parameter (Table [1](#tbl1){ref-type="other"} and Figure [5](#fig5){ref-type="fig"}A). This result indicates that the effect of latA is not due to an increase in vesicular content, but rather to alterations of the fusion pore kinetics.

![Single *versus* double exponential analysis. (A) Histograms of the fall time *t*~fall~, for the control, 1 μM latA and 100 μM [l]{.smallcaps}-DOPA treatments; the blue dotted bar indicates the position of the maximum of the distribution for the control case. (B) Scheme defining the normalized distance *d* to the "*T*~1~ = *T*~2~" line used in the analysis. (C) Single *versus* double exponential analysis showing the cumulative histograms of the normalized distance, *d*, for the control, 1 μM latA, and 100 μM [l]{.smallcaps}-DOPA treatments.](cb-2013-00665f_0006){#fig5}

Previous studies have reported that a double exponential (here referring to a sum of two exponentials), containing a fast and a slow component, might be a better fit than a single exponential to the decaying section of the peak.^[@ref28],[@ref31]−[@ref34]^ Several explanations, such as diffusional filtering, have been suggested, but in this section, we now reconsider the two-exponential fit by assuming an extended kiss-and-run mechanism, *i.e.*, that the pore closes again at the end of the event. According to numerical modeling, in the case of a fixed or opening pore, the asymptotic behavior of the clearance curve is a single exponential.^[@ref12]^ In this case, the asymptotic decay of the exocytotic current is mostly controlled by diffusion of the neurotransmitters through the fusion pore. As a consequence, a perfect single exponential asymptotic behavior strongly hints that the pore does not close again (*i.e.*, is stable or opening) during the course of the exocytotic release. On the basis of this observation, we suggest that the secondary exponential term is an indication of the last possible case, *i.e.*, the collapse of the pore, the secondary exponential being related to the closing kinetics of the lipid nanotube.^[@ref35]^ A last possibility, in the case of a single exponential decay, is that this part of the peak is controlled by the pore constriction only. This would necessarily mean that the content of the vesicle remains almost stable and hence that only a small fraction of transmitter is released. This would be in complete contradiction with the finding that about 40% of the content is released.^[@ref10],[@ref11]^ We therefore consider two situations: a purely diffusive case, where the decay is controlled by the diffusion of the neurotransmitters out of the vesicle (single exponential), and a second case where this efflux is also constrained by a closing pore (double exponential).

As a consequence, the decay of all of the peaks observed in our experiments was fit with a double decaying exponential to further understand the mechanisms controlling the fusion pore:where *t*~0~ is the starting time of the decay, and *T*~1~ and *T*~2~ are the characteristic decay times (with *T*~1~ ≤ *T*~2~). If a single exponential provides a better fit, a criterion would be that *T*~1~*≈ T*~2~.

The normalized distance, *d*, between the point (*T*~1~, *T*~2~) and the line describing the identity function is used as a criterion for evaluating whether a decay is better fit with a single or double exponential (Figure [5](#fig5){ref-type="fig"}B). If *d* is small, then the *T*~1~*≈ T*~2~ condition is satisfied and this peak is better fit with a single exponential. The normalized distance *d* is calculated as follows:where ∥(*T*~1~, *T*~2~)∥ is the norm of the vector (*T*~1~, *T*~2~), and θ is the angle formed by the vectors (*T*~1~, *T*~2~) and (1, 1). This parameter was calculated for every peak. Indeed, the main goal of our method is to discriminate those peaks better fit with a double exponential from those better fit with a single exponential. As shown in eq [1](#eq1){ref-type="disp-formula"}, four parameters are obtained from our fitting, and all of them are expected to carry specific information. The factors *A*~1~ and *A*~2~ are simply indicative of the scaling of the two exponentials and do not determine the nature of the curve (*i.e.*, single or double exponential). However, by focusing on the two characteristic times *T*~1~ and *T*~2~ and using the *T*~1~*≈ T*~2~ criterion and the normalized distance *d*, it is then possible to reduce the problem to these two variables, to address the single *versus* double exponential problem.

Figure [5](#fig5){ref-type="fig"}C shows the cumulative histograms obtained for *d*, for each treatment. The *y*-axis shows the calculated *d*, and the *x*-axis the fraction of the peak population whose *d* is below this value. For example, for the control treatment, about 50% of the peaks show a *d* below 0.1. Each of the histograms has then been fit with a sigmoid. The latA treatment displaces the center of this sigmoid to the right (control, 0.60; 1 μM latA, 0.79). This indicates that the latA treatment reduces the prevalence of high *d* values, thus favoring the single exponential decay. As the second exponential fitting is considered to be evidence for pore constriction, this result suggests, in good agreement with the increased *t*~fall~ value, that disruption of the actin network reduces the rate of contraction of the pore during the decay of the peak.

The single *versus* double exponential analysis was repeated for the [l]{.smallcaps}-DOPA-treated cells. The result of this analysis is shown in Figure [5](#fig5){ref-type="fig"}C. Even though both latA and [l]{.smallcaps}-DOPA induce larger, broader, and higher peaks, they have opposite effects on the distribution of the normalized distance, *d*. [l]{.smallcaps}-DOPA increases this occurrence of double exponential decays, thus indicating that the effect of the pore on the shape of the peak is more important in comparison to control. This increase probably indicates a stronger contribution of the closing of the pore on the vesicular efflux, in this case where the vesicular content is 50% higher than for control.^[@ref11]^ This is also an important control to establish the viability of our method. Indeed, it could be possible that the double exponential arise from another factor than the competition between release and pore constriction. For instance, one exponential could be from the exocytotic signal, and the other one from the noise. As the signal-to-noise ratios are comparable in the latA and [l]{.smallcaps}-DOPA cases, the different single *versus* double exponential distributions are therefore induced by specific characteristics of the exocytotic peaks. This result supports the viability of the method presented here indicating biological factors.

A rigorous analysis of the exact physical meaning of *T*~1~ and *T*~2~ exceeds the scope of the present study, but qualitative considerations can be brought to the discussion. As explained above, we assume that two distinct phenomena, the depletion of the vesicle and the constriction of the pore, are described by *T*~1~ and *T*~2~. The current measured at the electrode results from the efflux of neurotransmitters out of the vesicle, *via* the fusion pore, driven by the chemical potential energy of the higher concentration of neurotransmitter inside the vesicle. Hence, for the pore constriction to have an effect on the vesicular efflux, the rate of constriction of the pore has to be faster than the rate of diffusion out of the vesicle. From this observation, we can assume that, as *T*~1~ ≤ *T*~2~ by definition, *T*~1~ is characteristic of the pore constriction and *T*~2~ of the depletion of the vesicular content.

As shown in Table [2](#tbl2){ref-type="other"}, for the peaks better fit with a double exponential (*i.e.*, the ones corresponding to *d* \> 0.5), the experimental values for *T*~1~ have been found to be increased by both the latA and [l]{.smallcaps}-DOPA treatments, in comparison to control. However, only the [l]{.smallcaps}-DOPA treatment was found to significantly increase *T*~2~. On the basis of the qualitative analysis of the roles of *T*~1~ and *T*~2~ and the fact that *T*~1~ may be principally indicative of the constriction of the pore, these data support the idea that the constriction of the pore is slower when the cells are exposed to latA. Thus, the rate of depletion of the vesicular content is, in comparison, largely unaltered, and the intact actin network appears to participate in the closing of the fusion pore. The observation that both *T*~1~ (constriction of the pore) and *T*~2~ (rate of depletion of the vesicular content) are changed by the [l]{.smallcaps}-DOPA treatment can be explained by the increased vesicular packing. Due to the higher amount of material, it will take a longer time to deplete the cell (higher *T*~2~), and the higher tension in the vesicle membrane, due to the vesicle swelling, is expected to alter the properties of the pore (higher *T*~1~, ref ([@ref29])).

###### Experimental Results for *T*~1~ and *T*~2~ Obtained from K^+^-Stimulated PC12 Cells, for Peaks with *d* \> 0.5[a](#t2fn1){ref-type="table-fn"}

  treatment                     *T*~1~ (ms)      *T*~2~ (ms)
  ----------------------------- ---------------- -------------------
  control                       0.9 (0.5--1.5)   8.4 (5.6--11.7)
  1 μM latA                     1.8 (0.9--2.2)   11.9 (8.0--17.3)
  variation                     +91% (0.0004)    +42% (0.0109)
  100 μM [l]{.smallcaps}-DOPA   1.5 (1.1--2.3)   14.4 (11.5--23.6)
  variation                     +65% (0.0001)    +72% (0.0000)

Comparing control (10 cells, 71 peaks) to exposure to 1 μM latA (10 cells, 46 peaks) or to 100 μM [l]{.smallcaps}-DOPA (5 cells, 53 peaks). The data are presented as median (1st quartile--3rd quartile). The values reported in this table are the ones obtained for the peaks better fit with a double exponential. The criterion of selection for these peaks was *d* \> 0.5. The variation of the median in comparison to the control is reported. The pairs of data sets were compared using a two-tailed Wilcoxon--Mann--Whitney rank-sum test, and the result is indicated, between brackets, next to the variation of the median.

One of the main variations in the peak characteristics after the latA treatment is the observed increase in peak fall time. The decaying part of the peak is expected to contain some information about the closing of the fusion pore in extended kiss-and-run release.^[@ref10]^ In this case, the increased fall time is evidence that the inhibition of actin polymerization increases the lifetime of the pore and slows down the collapse of the pore. This strongly suggests that actin is an important factor in the closing dynamics of the lipid pore. This observation agrees with the results of the single *versus* double exponential analysis. The comparison of the peaks obtained with the latA treatments to the those obtained after the [l]{.smallcaps}-DOPA incubation is particularly informative as these treatments lead to an increased release amount but have opposite effects on the *T*~1~ and *T*~2~ distributions. This further demonstrates that latA and [l]{.smallcaps}-DOPA increase the release amount *via* different pathways.

Proposed Role for Actin in Exocytosis {#sec2.5}
-------------------------------------

The results presented here underline the role of actin polymerization in controlling the dynamics of exocytotic release. More precisely, inhibition of actin leads to an increase in the amount of molecules released and to a decrease in the rate of closing of the fusion pore. Modulation of the dynamics of exocytosis by the cytoskeleton, although controversial, in fact agrees with several reports of release heterogeneity over the cell surface.^[@ref36]−[@ref40]^ Furthermore, it has been found that events measured at the base of the cell are different from the ones made at its apex.^[@ref41],[@ref42]^ In light of the results presented here, it is reasonable to suggest that this heterogeneity might arise from the structure of the cytoskeleton.

Exocytosis was initially thought to lead to the full distension of the vesicle and to its integration into the cell membrane. However, several studies now support the occurrence of a mechanism that more resembles an extended kiss-and-run process, where only a fraction of the vesicular content is released.^[@ref43],[@ref44]^ In good agreement with this hypothesis, PC12 cell vesicles release only 40% of their content during exocytosis.^[@ref10],[@ref11]^ In our study, a 40% increase of the median of the amount released is observed (this corresponds to a 51% increase of the mean release; see Table S1 in the [Supporting Information](#notes-1){ref-type="notes"}). The probability to obtain large events (*\>*200 000 molecules released) is also increased (Figure [4](#fig4){ref-type="fig"}). As this phenomenon might be induced by a higher vesicular packing, the latA results have also been compared to the effect of [l]{.smallcaps}-DOPA.^[@ref11]^ It was then found that a latA-induced increase in vesicular packing is unlikely and that the observed increase in the amount of molecules released is probably due to an alteration of the pore dynamics. Altogether, the analysis presented indicates that the inhibition of actin leads to a reduced contribution of the fusion pore on the recorded exocytotic peak. We thus suggest that actin is involved in regulating the closing dynamics of the pore, thus controlling the decaying part of the amperometric peak. These findings strongly support the theory of partial release at PC12 cells and that actin is involved in regulating the amount of vesicular content released during extended kiss-and-run exocytosis.

Interestingly, actin is known to interact with several membrane-shaping chemical motors, such as dynamin.^[@ref45]−[@ref47]^ This GTPase has recently been found to, in part, regulate the fate of the fusion pore, probably by mediating its dilation.^[@ref35],[@ref48]−[@ref50]^ Together with the data presented here, we suggest that the regulation of the fusion pore dynamics is a competitive process between different mechanochemical transducers, as summarized in Figure [6](#fig6){ref-type="fig"}. In this case, dynamin, at least in part, promotes the opening of the pore, and actin its closure. The composition of the lipid membrane also plays a critical part.^[@ref6],[@ref7]^ However, this list is not exhaustive, as other polymers, proteins, or lipid structures might clearly contribute to this highly dynamic and competitive process.

![Proposed scheme for the contribution of dynamin and actin to exocytosis. Actin appears to force the closing of the pore, whereas dynamin promotes its opening.^[@ref35]^ The resulting typical amperometric spikes are presented below (not drawn to scale). Exposure to latrunculin A induces higher, wider peaks, and inhibition of the GTPase activity of dynamin with the inhibitor dynasore induces shorter, narrow peaks.^[@ref35]^](cb-2013-00665f_0007){#fig6}

From these results, we suggest that in PC12 cells the actin cytoskeletal scaffold contributes, probably with the lipid membrane and the protein machinery, to the closing dynamics of the pore. Thus, the cytoskeleton likely regulates the vesicular fraction released in an extended kiss-and-run mode.^[@ref10]−[@ref12]^ We have recently shown that dynamin is involved in holding open the pore during exocytosis,^[@ref35]^ so it appears likely that actin and dynamin complement each other in balancing and controlling release during an open and closed exocytosis process.

Methods {#sec3}
=======

The experimental details and procedures for the cell culture, the electrochemical measurements, and the data processing are provided as [Supporting Information](#notes-1){ref-type="notes"}.

Details on our experimental procedures and two additional tables where the mean of the data was computed in place of the median. This material is available free of charge *via* the Internet at <http://pubs.acs.org>.
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